Janciauskiene S, Eriksson S
Department of Medicine, Malmö General Hospital, University of Lund, Sweden.
FEBS Lett. 1993 Feb 1;316(3):269-72. doi: 10.1016/0014-5793(93)81306-k.
The in vitro interaction between human alpha 1-proteinase inhibitor (alpha 1-PI) and cholesterol was studied with electrophoretic and gel chromatographic methods. The addition of cholesterol (from 1 to 20 mol/mol alpha 1-PI) at 37 degrees C resulted in retarded electrophoretic mobility of alpha 1-PI towards the anode, diminished immunoreactivity and antiproteinase activity. At a molar ratio of 2:1 (cholesterol/alpha 1-PI), antitryptic activity was reduced by 15% but antielastase activity by 50%. At this ratio the gel filtration alpha 1-PI peak appeared at 67 kDa, as compared to 52 kDa for native alpha 1-PI. No size difference was noted on SDS-PAGE. These results suggest the occurrence of noncovalent complex formation between cholesterol and alpha 1-PI in vitro.
采用电泳和凝胶色谱法研究了人α1-蛋白酶抑制剂(α1-PI)与胆固醇在体外的相互作用。在37℃下添加胆固醇(1至20摩尔/摩尔α1-PI)会导致α1-PI向阳极的电泳迁移率减慢、免疫反应性降低和抗蛋白酶活性降低。在摩尔比为2:1(胆固醇/α1-PI)时,抗胰蛋白酶活性降低了15%,但抗弹性蛋白酶活性降低了50%。在此比例下,凝胶过滤α1-PI峰出现在67 kDa处,而天然α1-PI为52 kDa。在SDS-PAGE上未观察到大小差异。这些结果表明胆固醇与α1-PI在体外形成了非共价复合物。